Prosecution Insights
Last updated: April 19, 2026

Intercept Pharmaceuticals Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17615186 PHARMACEUTICAL COMPOSITIONS COMPRISING A FXR AGONIST AND A FIBRATE FOR USE IN THE TREATMENT OF CHOLESTATIC LIVER DISEASE ELENISTE, PIERRE PAUL 1622 Final Rejection Nov 30, 2021
17342057 METHODS AND INTERMEDIATES FOR THE PREPARATION OF BILE ACID DERIVATIVES PECKHAM, RICHARD GRANT 1627 Non-Final OA Jun 08, 2021

Managing Intercept Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month